lusopress
istituto luso farmaco d´ italia s.p.a., taliansko - nitrendipín - 58 - hypotensiva
Čapíky vaginálne alkagin
istituto ganassini s.p.a. di ricerche biochimiche via p. gaggia 16 20139 miláno taliansko -
sprej na intim hygienu alkagin
istituto ganassini s.p.a. di ricerche biochimiche via p. gaggia 16 20139 miláno taliansko -
pylclari
curium pet france - piflufolastat (18f) - prostatické nádory - diagnostické rádiofarmaká - tento liek je určený len na diagnostické účely. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).